BOSTON, March 4, 2024 /PRNewswire/ — Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the first patient was dosed March 3, 2024, in the Company’s phase 2 clinical trial…

BOSTON, March 4, 2024 /PRNewswire/ — Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the first patient was dosed March 3, 2024, in the Company’s phase 2 clinical trial…

NEW YORK, March 4, 2024 /PRNewswire/ — The chemical distribution market is to grow by USD 77.43 billion between 2022 and 2027 and register a CAGR of 5.2%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers,…

NEW YORK, March 4, 2024 /PRNewswire/ — The chemical distribution market is to grow by USD 77.43 billion between 2022 and 2027 and register a CAGR of 5.2%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.